BOSTON, MA and LONDON, UK, November 12, 2026
Instem, a leading provider of software solutions and scientific services for drug discovery and development, today announced a strategic partnership with Sable Bio to transform how biopharmaceutical organisations evaluate target safety and risk.
The partnership enhances KnowledgeScan™, Instem's established target risk assessment solution, by integrating Sable Bio's advanced Target Intelligence platform. Delivered as a cloud-based SaaS offering, KnowledgeScan enables researchers to rapidly generate target intelligence reports while providing the option to leverage Instem's scientific experts for deeper analysis, interpretation, and strategic guidance.
Through a combination of AI-driven literature intelligence with expert scientific review, KnowledgeScan helps organizations identify potential safety liabilities earlier, evaluate a broader body of scientific information, and make more informed development decisions with greater speed and confidence.
"By integrating Sable Bio's innovative Target Intelligence technology into KnowledgeScan, we're creating a powerful new approach to target evaluation. Our clients benefit from immediate access to high-value scientific insights while retaining the expert interpretation and contextual understanding that remain essential for effective decision-making in drug development," said Vik Krishnan, CEO at Instem.
"Together, Sable and Instem are combining advanced intelligence capabilities with deep domain expertise to help researchers evaluate potential risks faster, reduce manual effort, and focus resources on the most promising development opportunities," said Josh Almond-Thynne, CEO at Sable Bio.
Key Benefits
Immediate access to comprehensive target intelligence
Increased scientific productivity through automation and broader evidence discovery
Expert interpretation from experienced safety scientists
Faster target evaluation and improved confidence in development strategy
For more information on KnowledgeScan, read Instem's announcement.
About Sable Bio
Sable Bio provides advanced Target Intelligence solutions that help drug discovery and safety teams rapidly access, evaluate, and act upon complex safety data.
About Instem
Instem is a leading provider of software solutions, scientific services, and data-driven technologies that help organizations bring life-enhancing products to market faster and more safely.
Media contact
Shannon Johnson- Head of Operations, Sable Bio